Respiratory

Coming Soon

Edesa Biotech (Nasdaq: EDSA) posts Phase 3 ARDS results: 25% lower death risk, recovery - Stock Titan [Visit Site | Read More]

GSK and Empirico enter license agreement for clinical-stage, first-in-class oligonucleotide candidate to treat respiratory diseases - GSK [Visit Site | Read More]

As respiratory virus season begins, federal shutdown leaves critical gap in surveillance - CNN [Visit Site | Read More]

Oxytocin modulates respiratory heart rate variability through a hypothalamus–brainstem–heart neuronal pathway - Nature [Visit Site | Read More]

What to know about COVID, flu, RSV vaccines amid respiratory virus season - ABC News - Breaking News, Latest News and Videos [Visit Site | Read More]